Join to access to all OVN content. Join for Free
MSL Burnout...The Struggle is Real
MSL burnout stress management Medical Science Liaisons post-COVID challenges supportive teams

MSL Burnout...The Struggle is Real


Share This Article


Summary

In this episode, Jennifer Mohawk joins to discuss the prevalent issue of burnout among Medical Science Liaisons. She shares her insights on the common stressors, including overachievement and post-COVID challenges, that contribute to burnout in the MSL field. Jennifer addresses the impact of travel stress and the pressure of metrics, emphasizing the importance of recognizing early warning signs. She provides effective strategies for managing stress, such as midday movement and aligning personal and organizational values. The episode concludes with Jennifer's advice on building supportive, diverse teams and her final words of wisdom for MSLs.

My guest this week is Jennifer Mohawk, Senior Director, Medical Affairs with Apogee Therapeutics who discusses MSL burnout and how to handle the stress of the job.

Jen shares….

πŸ‘‰ What is MSL Burnout?
πŸ‘‰ How to pick up the warning signs
πŸ‘‰ What Managers can do to help with burnout
πŸ‘‰ What are ways to minimize and cope with the stress of the job
πŸ‘‰ What habits should be adopted for MSL sanity

Click for Source
MSL burnout, stress management, Medical Science Liaisons, post-COVID challenges, supportive teams

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN